Pragmatic applications of implementation science frameworks to regulatory science: an assessment of FDA Risk Evaluation and Mitigation Strategies (REMS) (2014–2018)

Abstract Background A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program for certain medications with serious safety concerns required by the U.S. Food and Drug Administration (FDA) of manufacturers to implement to help ensure the benefits of the medication outweigh its risks. F...

Full description

Bibliographic Details
Main Authors: Linda Huynh, Gita A. Toyserkani, Elaine H. Morrato
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Health Services Research
Subjects:
FDA
Online Access:https://doi.org/10.1186/s12913-021-06808-3